ALZAMEND NEURO, INC. Public Float
ALZAMEND NEURO, INC. (ALZN) had Public Float of $9.60 million as of 2025-10-31, per its 10-K filed 2026-07-22.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-07-22
- 2025-10-31: Entity Public Float $9.60M.
- 2024-10-31: Entity Public Float $8.20M.
- 2023-10-31: Entity Public Float $6.70M.
- 2022-10-31: Entity Public Float $66.40M.
| Period end | Entity Public Float |
|---|---|
| 2025-10-31 | $9.60M 10-K · filed 2026-07-22 |
| 2024-10-31 | $8.20M 10-K · filed 2025-07-22 |
| 2023-10-31 | $6.70M 10-K · filed 2024-07-30 |
| 2022-10-31 | $66.40M 10-K · filed 2023-07-27 |
| 2021-10-31 | $109.10M 10-K · filed 2022-07-19 |
| 2020-10-31 | $745.10M 10-K · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |